Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension

Resistant arterial hypertension is characterized by failure to control target blood pressure despite long-term use of optimal or maximum tolerated doses of three different antihypertensive drugs, including diuretic. Patients with resistant hypertension are included in a group of people at high risk...

Повний опис

Бібліографічні деталі

Автори:	O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Столичная издательская компания 2024-10-01
Серія:	Рациональная фармакотерапия в кардиологии
Предмети:	resistant arterial hypertension kidney epithelial sodium channels rho gtp-ase rac1 aldosterone synthase inhibitors mineralcorticoid receptor antagonists baxdrostat finerenone
Онлайн доступ:	https://www.rpcardio.online/jour/article/view/3064
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!